021-51111890
购物车（0）
sales@molnova.cn
ZD-2138
CAS No. 140841-32-3
ZD-2138 ( —— )
产品货号. M36250 CAS No. 140841-32-3
ZD-2138 is a potent and selective specific inhibitor of 5-lipoxygenase (5-LOX) that inhibits allergen-induced pulmonary bronchoconstriction and reduces neurally-induced fast-acting kallikrein-ergic constriction of isolated airways in guinea pigs.ZD-2138 can be used for the treatment of asthma disease.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥1718 | 有现货 |
|
| 5MG | ￥2584 | 有现货 |
|
| 10MG | ￥3795 | 有现货 |
|
| 25MG | ￥6037 | 有现货 |
|
| 50MG | ￥8446 | 有现货 |
|
| 100MG | ￥11169 | 有现货 |
|
| 500MG | ￥22338 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称ZD-2138
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述ZD-2138 is a potent and selective specific inhibitor of 5-lipoxygenase (5-LOX) that inhibits allergen-induced pulmonary bronchoconstriction and reduces neurally-induced fast-acting kallikrein-ergic constriction of isolated airways in guinea pigs.ZD-2138 can be used for the treatment of asthma disease.
-
产品描述ZD-2138 is a potent and selective specific inhibitor of 5-lipoxygenase (5-LOX) that inhibits allergen-induced pulmonary bronchoconstriction and reduces neurally-induced fast-acting kallikrein-ergic constriction of isolated airways in guinea pigs.ZD-2138 can be used for the treatment of asthma disease.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Immunology/Inflammation
-
靶点Lipoxygenase
-
受体Lipoxygenase
-
研究领域——
-
适应症——
化学信息
-
CAS Number140841-32-3
-
分子量397.44
-
分子式C23H24FNO4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO(C)C1(CCOCC1)C2=CC(OCC=3C=C4C(=CC3)N(C)C(=O)C=C4)=CC(F)=C2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
